ZETA PHARMA
Loading

We Strive to: ConquerThe Global Health Challenge

  • Towards a Life Without Pain

  • Keeping You Safe and Sound

  • Growing Healthy Together

Life Without Hepatitis C

Life Without Hepatitis C

Our main mission is a life without Hepatitis C, targeting to eradicate the disease from the Middle East and Africa regions, where our special screening program has proved efficient for more than 50,000 patients. We embrace a full-cycle support service where we walk with our patients throughout their entire treatment journey, achieving a successful...
The ideal cost effective healthcare solutions

The ideal cost effective healthcare solutions

Demand for generic medicines continues to grow, driven by patent losses, ongoing efforts to cut healthcare cost and an increase in age and life-style related diseases, NEXICURE- Esomeprazole 20/40 mg MUPS tablet, Is unique PPI generic Esomeprazole with MUPS technology providing both high quality and cost effectiveness from ZETA PHARMA ZETA PHAR...
Social Responsibility

Social Responsibility

We are a part of a big community, and we recognize that our true strength and sustainability come from the people’s wellbeing. We are always trying to be as considerate and responsive as possible to our external environment and we make every effort to extend access to medicine for people everywhere and work for the greater good of our society.

Pipeline Research

ZETA PHARMA® was established in 2010 to represent an added value in the pharmaceutical industry in Egypt through:
Establishing one of the best manufacturing facilities in the Middle East referenced by the international standards (GMP).
Building a well selected and unique product portfolio in the main therapeutic areas, which ensure that community has the most efficient and up-to-date treatment that directly contributes to improving health care and quality of their life.

Beginning in 2015, ZETA PHARMA® actively contribute to treating Hepatitis C virus in Egypt through its products:
Sofocivir ™, Zetaciver™, Sofocivir plus™

Our Strategy

Based on our intensive strategy during introduction and growing stages, we made our focus on organic growth which translating our expansion plan by investing in multiple therapeutic areas such as gastroenterology, cardiovascular and metabolic disorders. Recently we activated the inorganic way started with creating new channel of distribution and international partnerships by exporting our products to many countries in Eastern Europe, in parallel we had established and run a lot of contracts of partnerships with national and international partners/investors.

Patient Support

Our medicines, vaccines and consumer healthcare products are improving quality of life for patients and consumers around the world. But millions of people are still not getting the vaccines and treatments they need because they can't afford them, they can't get them locally, or they simply don't exist. Many countries continue to have under-resourced health systems. To play our part in tackling these global health challenges and extend the benefits of our products to more people, we are using open innovation to target unmet medical needs, pioneering new business models to increase access to our products and collaborating to strengthen healthcare infrastructure.

We Strive to Conquer The Global Health

Challenge

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod


Watch the Video

79
Developed Products
3,540,000
No. of Sold Packs
89,971
No. of Treated Patients
+100
Zeta Experts